Gå direkt till huvudinnehållet

Migrän

Senast uppdaterad: Senast reviderad:
Sakkunnig:
Definition:
Episodisk huvudvärk som karaktäriseras av olika kombinationer av neurologiska, gastrointestinala och autonoma förändringar.
Förekomst:
Ettårsprevalensen är 16 % bland kvinnor och 8 % bland män.
Symtom:
Anfall av huvudvärk, oftast halvsidig, som varar mellan 4 och 72 timmar med eller utan aura.
Kliniska fynd:
Mellan anfallen finns det vanligtvis inga kliniska fynd.
Diagnostik:
Typisk anamnes. Inga specifika undersökningar eller prover är av diagnostisk betydelse.
Behandling:
Anfallskupering – i första hand prövas enkla analgetika (paracetamol eller NSAID), i andra hand triptaner, eventuellt i kombination med NSAID. Förebyggande behandling – undvika utlösande faktorer, eventuellt beteendeterapi och/eller läkemedelsprofylax med i första hand betablockerare.
  1. Forde G, Duarte RA, Rosen N. . Managing Chronic Headache Disorders. Med Clin North Am 2016. pmid:26614723 PubMed  
  2. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211. PMID: 29368949 PubMed  
  3. Hagen K, Zwart J-A, Vatten L, Stovner LJ, Bovim G. Prevalence of migraine and non-migrainous headache. Head-HUNT - a large population based study. Cephalalgia 2000; 20:900-6. PubMed  
  4. Dias A, Mariz T, Sousa A, Lemos C, Alves-Ferreira M. A review of migraine genetics: gathering genomic and transcriptomic factors. Hum Genet. 2021 Oct 22. doi: 10.1007/s00439-021-02389-7. Epub ahead of print. PMID: 34686893 PubMed  
  5. Brandes JL. The influence of estrogen on migraine. JAMA 2006; 295: 1824-30. PubMed  
  6. Romanello S, Spiri D, Marcuzzi E, et al. Association between childhood migraine and history of infantile colic. JAMA 2013; 309: 1607-12. doi:10.1001/jama.2013.747. DOI  
  7. Charles A. Migraine. N Engl J Med 2017; 377: 553-61. pmid:28792865 PubMed  
  8. Stensland SØ, Zwart JA, Wentzel-Larsen T, Dyb G. The headache of terror: A matched cohort study of adolescents from the Utøya and the HUNT Study. Neurology 2017 Dec 13; Epub: pii: 10.1212/WNL.0000000000004805. pmid:29237795 PubMed  
  9. Giffin NJ, Ruggiero L, Lipton RB, et al. A novel approach to the study of premonitory symptoms in migraine using an electronic diary. Neurology 2003; 60: 935-40. Neurology  
  10. Thomsen LL, Eriksen MK, Roemer SF, Anderson I, Olesen J, Russell MB. A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain 2002; 125: 1379-99. PubMed  
  11. Silberstein SD. Migraine symptoms: results of a survey of self-reported migraineurs. Headache 1995; 35: 387-96. PubMed  
  12. Starling AJ, Vargas BB. A Narrative Review of Evidence-Based Preventive Options for Chronic Migraine. Curr Pain Headache Rep. 2015. pmid:26286071 PubMed  
  13. Duncan CW, Watson DPB, Stein A, et al. Diagnosis and management of headache in adults; summary of SIGN guideline. BMJ 2008; 337: a2329. BMJ (DOI)  
  14. Rabbie R, Derry S, Moore RA. Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2013 Apr 30;4. PMID: 23633348. PubMed  
  15. Law S, Derry S, Moore RA. Naproxen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2013 Oct 20;10:CD009455. PMID: 24142263. PubMed  
  16. Gilmore B, Michael M. Treatment of acute migraine headache. Am Fam Physician 2011; 83: 271-80. American Family Physician  
  17. Lipton RB, Stewart WF, Stone AM, Lainez MJA, Sawyer JPC. Stratified care vs step care strategies for migraine. The disability in strategies of care (DISC) study: a randomized trial. JAMA 2000; 284: 2599-605. Journal of the American Medical Association  
  18. Cameron C, Kelly S, Hsieh SC et al. Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis. Headache. 2015;55 Suppl 4:221-35.
  19. Law S, Derry S, Moore RA. Sumatriptan plus naproxen for acute migraine attacks in adults. Cochrane Database Syst Rev. 2013 Oct 21;10:CD008541. doi: 10.1002/14651858.CD008541.pub2. DOI  
  20. Migrän hos barn. Nationellt kliniskt kunskapsstöd. Hämtad 2021-11-19 nationelltklinisktkunskapsstod.se  
  21. Jeric M, Surjan N, Jelicic Kadic A et al. Treatment of acute migraine attacks in children with analgesics on the World Health Organization Essential Medicines List: A systematic review and GRADE evidence synthesis. Cephalalgia. 2017 Jan 1:333102417736902. PMID: 29034788 PubMed  
  22. Nappi RE, Berga SL. Migraine and reproductive life. Handb Clin Neurol. 2010;97:303-22 PubMed  
  23. Lee MJ, Guinn D et al. Headache in pregnancy. UpToDate, last updated Dec 02. 2020. UpToDate  
  24. Evans EW, Lorber KC. Use of 5-HT1 agonists in pregnancy. Ann Pharmacother 2008; 42: 543-9. PubMed  
  25. Derry CJ, Derry S, Moore RA. Sumatriptan (all routes of administration) for acute migraine attacks in adults - overview of Cochrane reviews. Cochrane Database Syst Rev. 2014 May 28. PMID: 24865446 PubMed  
  26. Bird S, Derry S, Moore RA. Zolmitriptan for acute migraine attacks in adults. Cochrane Database Syst Rev. 2014 May 21;5:CD008616. DOI: 10.1002/14651858.CD008616.pub2. DOI  
  27. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans in acute migraine treatment: a meta-analysis of 53 trials. Lancet 2001; 358: 1668-75. PubMed  
  28. Brandes JL, Kudrow D, Stark SR, et al. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. JAMA 2007; 297: 1443-54. Journal of the American Medical Association  
  29. Winner P, Rothner AD, Wooten JD, Webster C, Ames M. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study. Headache 2006; 46: 212-22. PubMed  
  30. Tfelt-Hansen P, Iversen HK. Triptaner i migrænebehandlingen. Ugeskr Læger 2006; 168: 1850-3. PubMed  
  31. Amundsen S, Nordeng H, Nezvalova-Henriksen K, Stovner LJ, Spigset O. Pharmacological treatment of migraine during pregnancy and breastfeeding. Nat Rev Neurol 2015; 11(4): 209-19. PMID: 25776823 PubMed  
  32. Colman I, Friedman BW, Brown MD et al. Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence . BMJ 2008; 336: 1359-61. PubMed  
  33. Singh A, Alter HJ, Zaia B. Does the addition of dexamethasone to standard therapy for acute migraine headache decrease the incidence of recurrent headache for patients treated in the emergency department? A meta-analysis and systematic review of the literature. Acad Emerg Med 2008; 15: 1223-33. PubMed  
  34. Bennett MH, French C, Schnabel A, et al. Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache. Cochrane Database Syst Rev. 2015 Dec 28;12:CD005219 Cochrane (DOI)  
  35. Riktlinje för migrän. NPO Nervsystemets sjukdomar. Nationellt Kliniskt kunskapsstöd. Hämtad 2023-02-16 nationelltklinisktkunskapsstod.se  
  36. Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA 2003; 289: 65-9. PubMed  
  37. Linde M, Mulleners WM, Chronicle EP, et al. Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev. 2013 Jun 24;6. PMID: 23797674. PubMed  
  38. PRAC rekommenderar ytterligare begränsning för användning av valproat hos kvinnor och flickor. Läkemedelsveket 2014-10-13. www.lakemedelsverket.se  
  39. Linde M, Mulleners WM, Chronicle EP, et al. Topiramate for the prophylaxis of episodic migraine in adults. Cochrane Database Syst rev. 2013 Jun 24;6. PMID: 23797676. PubMed  
  40. Marmura MJ. Safety of topiramate for treating migraines. Expert Opin Drug Saf. 2014 Sep;13(9):1241-7. doi: 10.1517/14740338.2014.934669. dx.doi.org  
  41. Hwang TJ, Vokunger KN, Kesselheim AS. New Treatments for Migraine—Therapeutic Ratings and Comparative Coverage in the US, Canada, and Europe. JAMA Intern Med 2021. pmid:34901995 PubMed  
  42. Jackson JL, Kuriyama A, Hayashino Y. Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis. JAMA 2012; 307: 1737-1745. www.ncbi.nlm.nih.gov  
  43. Simpson DM, Hallett M, AshmanEJ, et al. Practice guideline update summary: Botulinum neurotoxin for the treatment of plepharospasm, cervical dystonia, adult spasticity, and headache. Neurology 2016. doi:10.1212/WNL.0000000000002560 DOI  
  44. Herd CP, Tomlinson CL, Rick C, Scotton WJ, Edwards J, Ives NJ, Clarke CE, Sinclair AJ. Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine. BMJ Open. 2019 Jul 16;9(7):e027953. doi: 10.1136/bmjopen-2018-027953. PMID: 31315864 PubMed  
  45. Banzi R, Cusi C, Randazzo C, et al. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults. Cochrane Database Syst Rev. 2015 Apr 1;4:CD002919. PMID: 25829028. PubMed  
  46. Gabellari I, De Lorenzo C, Mana O, Benedetto. Oral contraceptives in migraine therapy. Neurol Sci. 2011 May;32 Suppl 1:S135-9
  47. Contag SA, Bushnell C. Contemporary management of migrainous disorders in pregnancy. Curr Opin Obstet Gynecol 2010; 22: 437-45. PubMed  
  48. Linde K, Allais G, Brinkhaus B, et al . Acupuncture for the prevention of episodic migraine. Cochrane Database Syst Rev 2016; Jun 28;6: CD001218. PMID:27351677. PubMed  
  49. Ni X, Dong L, Tian T, et al. Acupuncture versus Various Control Treatments in the Treatment of Migraine: A Review of Randomized Controlled Trials from the Past 10 Years. J Pain Res. 2020 Aug 12;13:2033-2064. PMID: 32884332 PubMed  
  50. Xu S, Yu L, Luo X, et al. Manual acupuncture versus sham acupuncture and usual care for prophylaxis of episodic migraine without aura: multicentre, randomised clinical trial. BMJ. 2020; 368: m697. PMID: 32213509 PubMed  
  51. Long C, Ye Y, Chen M, et al. Effectiveness of yoga therapy for migraine treatment: A meta-analysis of randomized controlled studies. Am J Emerg Med 2022; 58: 95-99. pmid:35660369 PubMed  
  52. Sharpe L, Dudeney J, Williams ACC, et al. Psychological therapies for the prevention of migraine in adults. Cochrane Database Syst Rev. 2019 Jul 2;7:CD012295. doi: 10.1002/14651858.CD012295.pub2. www.cochranelibrary.com  
  53. Wells RE, O`Connell N, Pierce CR, et al. Effectiveness of Mindfulness Meditation vs Headache Education for Adults With Migraine: A Randomized Clinical Trial. JAMA Intern Med. 2020. PMID: 33315046 PubMed  
  54. Mahmoud AN, Mentias A, Elgendy AY, Qazi A, Barakat AF, Saad M, Mohsen A, Abuzaid A, Mansoor H, Mojadidi MK, Elgendy IY. Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects. BMJ Open. 2018 Mar 27;8(3):e020498. doi: 10.1136/bmjopen-2017-020498. PMID: 29593023 PubMed  
  55. Allais G, Chiarle G, Bergandi F, et al.. Migraine in perimenopausal women. Neurol Sci. 2015. pmid:26017518 PubMed  
  • Anna Nager, docent och specialist i allmänmedicin, Karolinska institutet